Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roser Velasco

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Journal of Pain and Symptom Management|August 12, 2017
Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological StudyRoser Velasco, Xavier Navarro, Miguel Gil-Gil, et al.
Journal of the Peripheral Nervous System : JPNS|August 9, 2019
Immune checkpoint inhibitors-induced neuromuscular toxicity: From pathogenesis to treatmentDimitri Psimaras, Roser Velasco, Cristina Birzu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 6, 2019
Assessing risk factors of falls in cancer patients with chemotherapy-induced peripheral neurotoxicityAndreas A Argyriou, Jordi Bruna, Garifallia G Anastopoulou, et al.
Journal of Neuro-Oncology|March 13, 2012
Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapyMarta Simó, Roser Velasco, Francesc Graus, et al.
Journal of the Peripheral Nervous System : JPNS|June 11, 2016
Serum micronutrients and prealbumin during development and recovery of chemotherapy-induced peripheral neuropathyRoser Velasco, Cristina Santos, Gemma Soler, et al.
Neuro-Oncology|September 30, 2015
Lymphomatosis cerebri: a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literatureCristina Izquierdo, Roser Velasco, Noemí Vidal, et al.
BMC Cancer|July 21, 2025
Gender and age effects on the incidence and severity of chemotherapy-induced neuropathic pain: a propensity score matching analysisAndreas A Argyriou, Roser Velasco, Foteini Kalofonou, et al.
Journal of the Peripheral Nervous System : JPNS|February 4, 2024
Incidence and risk factors for developing chemotherapy-induced neuropathic pain in 500 cancer patients: A file-based observational studyAndreas A Argyriou, Jordi Bruna, Foteini Kalofonou, et al.
Epilepsy & Behavior : E&B|June 15, 2015
Refractory status epilepticus due to SMART syndromeSonia Jaraba, Oriol Puig, Júlia Miró, et al.
European Journal of Neurology|July 2, 2024
Plasma neurofilament light chain levels in chemotherapy-induced peripheral neurotoxicity according to type of anticancer drugRoser Velasco, Carla Marco, Eva Domingo-Domenech, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Journal of Pain and Symptom Management|August 12, 2017
Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological StudyRoser Velasco, Xavier Navarro, Miguel Gil-Gil, et al.
Journal of the Peripheral Nervous System : JPNS|August 9, 2019
Immune checkpoint inhibitors-induced neuromuscular toxicity: From pathogenesis to treatmentDimitri Psimaras, Roser Velasco, Cristina Birzu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 6, 2019
Assessing risk factors of falls in cancer patients with chemotherapy-induced peripheral neurotoxicityAndreas A Argyriou, Jordi Bruna, Garifallia G Anastopoulou, et al.
Journal of Neuro-Oncology|March 13, 2012
Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapyMarta Simó, Roser Velasco, Francesc Graus, et al.
Journal of the Peripheral Nervous System : JPNS|June 11, 2016
Serum micronutrients and prealbumin during development and recovery of chemotherapy-induced peripheral neuropathyRoser Velasco, Cristina Santos, Gemma Soler, et al.
Neuro-Oncology|September 30, 2015
Lymphomatosis cerebri: a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literatureCristina Izquierdo, Roser Velasco, Noemí Vidal, et al.
BMC Cancer|July 21, 2025
Gender and age effects on the incidence and severity of chemotherapy-induced neuropathic pain: a propensity score matching analysisAndreas A Argyriou, Roser Velasco, Foteini Kalofonou, et al.
Journal of the Peripheral Nervous System : JPNS|February 4, 2024
Incidence and risk factors for developing chemotherapy-induced neuropathic pain in 500 cancer patients: A file-based observational studyAndreas A Argyriou, Jordi Bruna, Foteini Kalofonou, et al.
Epilepsy & Behavior : E&B|June 15, 2015
Refractory status epilepticus due to SMART syndromeSonia Jaraba, Oriol Puig, Júlia Miró, et al.
European Journal of Neurology|July 2, 2024
Plasma neurofilament light chain levels in chemotherapy-induced peripheral neurotoxicity according to type of anticancer drugRoser Velasco, Carla Marco, Eva Domingo-Domenech, et al.
Pageof 6